|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
15
|
|
pubmed:dateCreated |
2006-7-18
|
|
pubmed:abstractText |
Impaired diastolic function is responsible for many of the clinical features of hypertrophic cardiomyopathy. In patients with hypertrophic obstructive cardiomyopathy (HOCM) whose symptoms are refractory to medical therapy, alcohol septal ablation (ASA) reduces left ventricular (LV) outflow tract gradient, with short-term improvement in LV diastolic function. Little is known about the longer term impact of ASA on diastolic function.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0195-668X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1805-10
|
|
pubmed:meshHeading |
pubmed-meshheading:16774986-Adult,
pubmed-meshheading:16774986-Aged,
pubmed-meshheading:16774986-Aged, 80 and over,
pubmed-meshheading:16774986-Cardiomyopathy, Hypertrophic,
pubmed-meshheading:16774986-Echocardiography,
pubmed-meshheading:16774986-Ethanol,
pubmed-meshheading:16774986-Female,
pubmed-meshheading:16774986-Heart Septum,
pubmed-meshheading:16774986-Humans,
pubmed-meshheading:16774986-Male,
pubmed-meshheading:16774986-Middle Aged,
pubmed-meshheading:16774986-Sclerosing Solutions,
pubmed-meshheading:16774986-Solvents,
pubmed-meshheading:16774986-Treatment Outcome,
pubmed-meshheading:16774986-Ventricular Dysfunction, Left
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
|
|
pubmed:affiliation |
Cardiac Ultrasound Laboratory, Cardiology Division, Massachusetts General Hospital, Boston, MA 02114, USA.
|
|
pubmed:publicationType |
Journal Article
|
